Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium.

Eradication of Helicobacter pylori with currently available antibacterial agents is unsatisfactory due to the risk of side-effects and the emergence of resistance. The organism rapidly dies in vitro in the presence of urea at pH 6. When incubated in citrate buffer (pH 6) plus urea (10 mM) the five minute survival was 26% compared with 96% without urea and the survival progressively decreased with increasing urea concentrations, being only 9% in 50 mM urea. The bactericidal effect depended on pH as the organism survived in citrate buffer (pH 7) plus urea (50 mM). The death of the organism at pH 6 in the presence of urea was prevented by the addition of the competitive urease inhibitor hydroxyurea. These findings indicate that destruction of the organism is mediated by its exceptionally high urease activity. Harnessing this enzyme to induce self-destruction could provide a new approach to eradicating this common infection.

[1]  K. McColl,et al.  Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. , 1991, Gut.

[2]  D. Vos,et al.  Metronidazole resistance in Helicobacter pylori , 1990, The Lancet.

[3]  H. Coleman,et al.  Lack of in vitro activity of omeprazole against Campylobacter pylori. , 1990, Journal of clinical pathology.

[4]  L. Barbara,et al.  OMEPRAZOLE, HELICOBACTER PYLORI, GASTRITIS, AND DUODENAL ULCER , 1989, The Lancet.

[5]  J. Jansen,et al.  Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. , 1989, Gut.

[6]  M. Delmée,et al.  OMEPRAZOLE, CAMPYLOBACTER PYLORI, AND DUODENAL ULCER , 1989, The Lancet.

[7]  S. Shousha,et al.  Gastric metaplasia and Campylobacter pylori infection of duodenum in patients with chronic renal failure. , 1989, Journal of Clinical Pathology.

[8]  A. Price,et al.  Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? , 1989, Gut.

[9]  B. Marshall,et al.  PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI , 1988, The Lancet.

[10]  S. Hazell,et al.  The urease enzymes of Campylobacter pylori and a related bacterium. , 1988, Journal of medical microbiology.

[11]  H. Mobley,et al.  Characterization of urease from Campylobacter pylori , 1988, Journal of clinical microbiology.

[12]  D. Graham,et al.  Epidemiology of Campylobacter pylori infection: ethnic considerations. , 1988, Scandinavian Journal of Gastroenterology, Supplement.

[13]  G. Cleghorn,et al.  The use of a synthetic prostaglandin E1 analogue (misoprostol) as an adjunct to pancreatic enzyme replacement in cystic fibrosis. , 1988, Scandinavian journal of gastroenterology. Supplement.

[14]  C. Simpson Cost effectiveness of postmortem histology. , 1987, Journal of clinical pathology.

[15]  D. Tompkins,et al.  Campylobacter pylori, acid, and bile. , 1987, Journal of clinical pathology.

[16]  J. O. Irwin,et al.  The estimation of the bactericidal power of the blood , 1938, Epidemiology and Infection.